Skip NavigationSkip to Content
Return Return to Search Results

Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets

  1. Author:
    Adamson, C. S.
    Freed, E. O.

  2. Author Address

    Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Maryland, 21702-1201, USA. cadamson@ncifcrf.gov
    1. Year: 2009
    2. Date: Apr
    3. Epub Date: 4/30/2009
  2. Journal: Molecular Interventions
    1. 9
    2. 2
    3. Pages: 70-4
  4. Type of Article: Article
  5. ISSN: 1543-2548 (Electronic)
  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1124/mi.9.2.5
  3. PMID: 19401538

Library Notes

  1. Fiscal Year: FY2008-2009
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel